Department of Oral Cell Biology, Academic Centre for Dentistry Amsterdam (ACTA), Amsterdam, The Netherlands.
School/Hospital of Stomatology, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Clin Exp Dent Res. 2022 Oct;8(5):1092-1102. doi: 10.1002/cre2.613. Epub 2022 Jul 7.
The evaluation of three different drug delivery modes of bone morphogenetic protein-2 (BMP-2) in healing peri-implant bone defects in beagle dogs. BMP-2 was incorporated in or onto calcium phosphate (CaP) granules in various ways: (i) directly on the outer layer of granules CaP: as an adsorbed depot; (ii) during the entire precipitation process of CaP: an internally incorporated depot; or (iii) during the biomimetic coating precipitation of BMP-2 on the surface of CaP granules: as a coating incorporated depot.
After extraction of the lower molars and wound healing in 6 male beagle dogs, 36 implants were placed (n = 6 animal per group). Peri-implant bone defects were induced. The following treatment groups were evaluated: no treatment; air abrasive surface cleaning (SC) using hydroxyapatite; SC and the subsequent filling of the defect with CaP without BMP-2; SC plus the subsequent filling of the defect with CaP adsorbed BMP-2; SC plus the subsequent filling of the defect with CaP internally incorporated BMP-2; SC plus the subsequent filling of the defect with CaP coating incorporated BMP-2. Histological and histomorphometric analyses were carried out to quantify and compare the changes in bone tissue surrounding the treated implants.
In Group 1 with no treatment, four implants were lost. Group 5 with the SC and the subsequent filling of the defect with internally incorporated BMP-2 biomimetically prepared CaP (BioCaP), whereby the BMP-2 is incorporated in the entire volume of all BioCaP particles, showed overall the best results to regenerate bone around the implants.
This study concluded that the group treated with SC plus the subsequent filling of the defect with CaP BMP-2 internally incorporated BMP-2, whereby BMP-2 has been incorporated in the entire volume of all CaP particles, showed overall the best results when aiming to regenerate bone around the implants.
评估骨形态发生蛋白-2(BMP-2)在治疗比格犬种植体周围骨缺损的三种不同给药方式。BMP-2 以不同的方式掺入或负载在磷酸钙(CaP)颗粒上:(i)直接在 CaP 颗粒的外层:作为吸附库;(ii)在 CaP 的整个沉淀过程中:作为内部掺入的库;或(iii)在 BMP-2 仿生涂层沉淀在 CaP 颗粒表面时:作为涂层掺入的库。
在 6 只雄性比格犬的下颌磨牙拔除和伤口愈合后,共植入 36 枚种植体(每组 6 只动物)。诱导种植体周围骨缺损。评估了以下治疗组:无治疗;使用羟基磷灰石进行空气喷砂表面清洁(SC);SC 后用不含 BMP-2 的 CaP 填充缺陷;SC 后用吸附 BMP-2 的 CaP 填充缺陷;SC 后用内部掺入 BMP-2 的 CaP 填充缺陷;SC 后用涂层掺入 BMP-2 的 CaP 填充缺陷。进行组织学和组织形态计量学分析以定量和比较处理种植体周围骨组织的变化。
在无治疗的第 1 组中,有 4 枚种植体脱落。第 5 组接受 SC 和随后用仿生制备的内部掺入 BMP-2 的 CaP(BioCaP)填充缺陷,其中 BMP-2 掺入所有 BioCaP 颗粒的整个体积,总体上显示出最好的结果,可在种植体周围再生骨。
本研究得出结论,接受 SC 加随后用内部掺入 BMP-2 的 CaP 填充缺陷治疗的组,其中 BMP-2 已掺入所有 CaP 颗粒的整个体积,在试图再生种植体周围的骨时总体上显示出最好的结果。